AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months after scoring similar approvals in the West. The Japanese Ministry of ...

AstraZeneca’s efforts to move its top oncology drugs into earlier treatment settings have been lifted by positive data for Tagrisso and Imfinzi in lung cancer.

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat a subset of non-small cell lung ...

AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer By Annika Kim Constantino, CNBC • Published June 17, 2025 • Updated on June 17, 2025 at ...

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer By Annika Kim Constantino, CNBC • Published June 17, 2025 • Updated on June 17, 2025 at ...

AstraZeneca AZN announced that the FDA has expanded the label of its cancer drug Datroway for a second indication — non-small cell lung cancer (NSCLC). The drug has been developed in partnership ...

Companies such as AstraZeneca, Daiichi Sankyo, Pfizer, Merck and GSK are learning from previous setbacks in the ADC space to develop drugs that improve efficacy and reduce side effects.